BBB Foods Inc.

BBB Foods reported second quarter 2026 revenue of MXN 26 billion, up 39% year-over-year, with same-store sales increasing 20%. Adjusted EBITDA excluding non-cash share-based compensation rose 44% to MXN 1.6 billion, and adjusted EBITDA margin expanded by 21 basis points year-over-year. The company opened 155 net new stores during the quarter, bringing total store count to 3,624 as of June 30, 2026, and opened one new distribution center, expanding its network to 21 regions. Operating cash flow for the first half of 2026 reached MXN 4.3 billion, a 119% increase compared to the first half of 2025. Management noted that approximately two-thirds of same-store sales growth was driven by volume and one-third by price, and that 100% of new stores open under the upgraded format.

BBB Foods, the Mexican parent of discount grocery chain Tiendas 3B, reported 20% same-store sales growth in the second quarter, driving revenue to 26 billion pesos, or roughly $1.5 billion, up 38.7% year over year. The company added 155 new stores in the quarter to reach 3,624 locations, expanding its base by about 16% annually, and plans to at least quadruple its footprint to 14,000 stores over the long term. Adjusted EBITDA margin, excluding share-based compensation, was 6.1%, and the company's price-to-sales ratio stands at 1. Tiendas 3B operates small-format stores of 3,000 to 4,500 square feet with private-label products accounting for more than 58% of merchandise sales, a model similar to Trader Joe's and Aldi.

Billionaire investor Stanley Druckenmiller's Duquesne Family Office disclosed its top five long positions, spanning a Mexican discount grocer, two biotech firms, a semiconductor giant, and an Argentine oil producer. The largest holding is BBB Foods, a hard-discount grocer in Mexico that grew revenue 33.44% year-over-year to roughly Ps.22.86 billion in Q1 2026, with same-store sales up 16.0%. Insmed, a rare-disease pharma, saw total revenue surge 229.6% to $305.96 million, driven by its newly launched bronchiectasis drug BRINSUPRI which contributed $207.90 million in its first full quarter. Taiwan Semiconductor Manufacturing posted Q2 2026 EPS of $4.31, beating consensus by 10.89%, on revenue of $40.20 billion, up 36.0% year-over-year. Natera, a precision-medicine company, processed over one million tests in a single quarter for the first time, with Q1 2026 revenue reaching $696.64 million, a 38.8% increase. YPF, Argentina's state-backed energy firm, swung to a $409 million net profit in Q1 2026 as shale oil production hit 205 kbbl/d, up 39% year-over-year, and lifting costs fell 42%, with its VMOS export pipeline targeting first oil in January 2027.